Skip to main content
. 2022 Mar 23;9:849990. doi: 10.3389/fmed.2022.849990

Figure 8.

Figure 8

Summary of RXRα mediated suppression of IL-17 production by γδ T cells and IL-17 mediated dry eye disease. RXRα suppresses the production of IL-17 inducers (IL-23, IL-1β, and TNF-α) by myeloid cells and directly suppresses IL-17 production by activated γδ T cells. IL-17 promotes corneal barrier disruption, increased expression of the cornified envelope precursor SPRR2 that decreases epithelial lubricity and seals goblet cell openings and reduction in mucin-filled conjunctival goblet cells.